Infection by the severe acute respiratory syndrome (SARS) coronavirus‑2 (SARS‑CoV‑2) is
the cause of the new viral infectious disease (coronavirus disease 2019; COVID‑19) …

The causative agent of the current pandemic and coronavirus disease 2019 (COVID-19) is
the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Understanding how …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), discovered in 2019, is
responsible for the global coronavirus disease 19 (COVID-19) pandemic. The main protein …

Neuropilin-1 (NRP-1), a member of a family of signaling proteins, was shown to serve as an
entry factor and potentiate SARS Coronavirus 2 (SARS-CoV-2) infectivity in vitro. This cell …

Nowadays, there is growing evidence of neurological abnormalities with coronavirus
disease 2019 (COVID-19)[1–3]. Nevertheless, in COVID-19 cases, the exact mechanisms of …

Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection can trigger
the adaptive and innate immune responses, leading to uncontrolled inflammatory reactions …

The recent outbreak of SARS-CoV-2 infections that causes coronavirus-induced disease of
2019 (COVID-19) is the defining and unprecedented global health crisis of our time in both …

Neurological manifestations are frequently reported in the COVID-19 patients.
Neuromechanism of SARS-CoV-2 remains to be elucidated. In this study, we explored the …

A major immunopathological feature of Coronavirus disease-2019 (COVID-19) is excessive
inflammation in the form of “cytokine storm”. The storm is characterized by injurious levels of …

Two recently published studies published in Science by Daly et al. 1 and Cantuti-Castelvetri
et al. 2 identified neuropilin-1 (NRP1) as an additional cellular mediator which may facilitate …